Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eva Schlede"'
Autor:
H Lessmann, Eva Schlede, T Fuchs, T Maurer, I Gerner, D Kayser, E Wagner, G Stropp, W Aberer, R Rossbacher
Publikováno v:
Dermatotoxicology, Seventh Edition ISBN: 9780849397738
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ab10fe5b3ae72ac2fe9d886d31510c1
https://doi.org/10.1201/9781420009774.ch91
https://doi.org/10.1201/9781420009774.ch91
Autor:
Eva Schlede, Rosemarie Eppler
Publikováno v:
Contact dermatitis. 32(1)
The notification procedure for new chemicals in the European Union (called the Chemicals Act in Germany) requires a skin sensitization test when the amount of a new chemical produced exceeds 100 kg/year. The preferred test is that of Magnusson and Kl
Autor:
Eva Schlede, Horst Scholz
Publikováno v:
Journal of Perinatal Medicine. 2:189-195
Cigarette smoking during pregnancy has been shown to increase the incidence of abortions, premature deliveries and lighter weight of the newborns. However, an explicit explanation for these findings is still lacking and until now it cannot be exclude
Autor:
Eva Schlede
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 282:311-315
The developmental pattern of benzo(a)pyrene hydroxylase and ethylmorphine N-demethylase from 8 days before birth up to 100 days of age in rat liver homogenate was investigated. These two drug metabolizing enzyme reactions exhibited their highest acti
Autor:
Eva Schlede, H. J. Merker
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 282:59-73
Treatment of pregnant rats with 40 mg benzo(a)pyrene (BP) per kg body weight p.o. 24 h prior to sacrifice results in an induction of BP hydroxylase activity in the whole implantation site, the decidua, the placenta, and the fetal membranes. In contro
Autor:
I. Roots, Eva Schlede
Publikováno v:
Toxicology Letters. 29:5-10
The impact of the genetic hydroxylation deficiency described for several drugs such as sparteine, debrisoquine, and phenformin, has been studied with respect to benzo(a)pyrene (BP) metabolite formation. 14 C-BP (80 μM) was incubated with liver micro
Autor:
Eva Schlede, R. Borowski
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 281:341-355
Pregnant and nonpregnant rats were treated with 37.5 mg phenobarbital (PB) per kg body weight twice daily for 4 days. Pregnant rats were injected with PB from day 10 to day 13 and from day 17 to day 20 of gestation and were used for the experiments o
Autor:
H. J. Merker, Eva Schlede
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 272(1)
Pregnant rats were treated with an oral dose of 40.0 mg benzo(α) pyrene (BP) per kg body weight and were sacrificed 24 h later. Maternal liver, placenta, and fetus were assayed for BP-hydroxylase activity. The enzyme activity was measured from day 1
Autor:
H. Kewitz, Eva Schlede
Publikováno v:
Naunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie. 259:211-212